MEETING THE BIODEFENSE CHALLENGE: A “ROADMAP” FOR A

0,27

MB

NATIONAL VACCINE STRATEGY

66

stron

4087

ID

Chemical and Biological Arms Control Institute

2004

rok

TABLE OF CONTENTS

Foreword . v

Working Group Participants vii

I. Introduction 1

II. Goals and Objectives . 5

III. Key Characteristics of a National Vaccine Strategy . 9

IV. Pros and Cons of Vaccines 13

V. Key Actors and Principal Stakeholders 17

VI. Critical Issues: Guideposts for the Roadmap . 21

Classes of Vaccines 21

Funding Vaccine Development and the Future Potential Vaccine Market . 23

Promoting Industry Engagement 25

Liability Issues . 29

Licensing Process for Vaccines . 32

Role of Patents . 32

Research and Development Priorities 33

Distribution and Dissemination . 35

Enhancing Public Understanding 36

Vaccines in the Public Health “Toolbox” . 38

VII. Final Notes 39

Appendix: Selected Bibliography . 41